The 36-month beta value for ICU is also noteworthy at -0.93. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for ICU is 59.71M, and at present, short sellers hold a 5.49% of that float. The average trading volume of ICU on May 06, 2024 was 5.38M shares.
ICU) stock’s latest price update
SeaStar Medical Holding Corp (NASDAQ: ICU)’s stock price has gone decline by -9.06 in comparison to its previous close of 0.49, however, the company has experienced a 1.91% increase in its stock price over the last five trading days. GlobeNewsWire reported 2024-04-11 that DENVER, April 11, 2024 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that management will present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference on Thursday, April 18 at 9:30 a.m. Eastern time. The formal presentation will be followed by a hosted question-and-answer session.
ICU’s Market Performance
ICU’s stock has risen by 1.91% in the past week, with a monthly drop of -37.23% and a quarterly drop of -44.62%. The volatility ratio for the week is 17.15% while the volatility levels for the last 30 days are 14.60% for SeaStar Medical Holding Corp The simple moving average for the past 20 days is -21.57% for ICU’s stock, with a -22.89% simple moving average for the past 200 days.
ICU Trading at -36.64% from the 50-Day Moving Average
After a stumble in the market that brought ICU to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.64% of loss for the given period.
Volatility was left at 14.60%, however, over the last 30 days, the volatility rate increased by 17.15%, as shares sank -35.68% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -59.59% lower at present.
During the last 5 trading sessions, ICU rose by +1.91%, which changed the moving average for the period of 200-days by -13.73% in comparison to the 20-day moving average, which settled at $0.5595. In addition, SeaStar Medical Holding Corp saw 1.33% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ICU starting from Van Heel Kenneth, who purchase 100,000 shares at the price of $0.40 back on Nov 22 ’23. After this action, Van Heel Kenneth now owns 116,400 shares of SeaStar Medical Holding Corp, valued at $40,000 using the latest closing price.
Chung Kevin, the Chief Medical Officer of SeaStar Medical Holding Corp, purchase 12,543 shares at $0.47 during a trade that took place back on May 30 ’23, which means that Chung Kevin is holding 68,125 shares at $5,953 based on the most recent closing price.
Stock Fundamentals for ICU
The total capital return value is set at 1.49. Equity return is now at value -103.15, with -633.62 for asset returns.
Based on SeaStar Medical Holding Corp (ICU), the company’s capital structure generated -1.9 points at debt to capital in total, while cash flow to debt ratio is standing at -1.13. The debt to equity ratio resting at -0.65. The interest coverage ratio of the stock is -13.15.
Currently, EBITDA for the company is -14.21 million with net debt to EBITDA at -0.63. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.18.
Conclusion
In summary, SeaStar Medical Holding Corp (ICU) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
